Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification
Author:
Funder
Beijing University of Chinese Medicine
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference77 articles.
1. Acetazolamide use in severe chronic obstructive pulmonary disease. Pros and cons;Adamson;Annals of the American Thoracic Society,2017
2. Endothelial stromelysin1 regulation by the forkhead box-O transcription factors is crucial in the exudative phase of acute lung injury;Artham;Pharmacol. Res.,2019
3. Regulation of pulmonary endothelial barrier function by kinases;Barabutis;Am. J. Physiol. Lung Cell Mol. Physiol.,2016
4. Hsp90 inhibitors suppress P53 phosphorylation in LPS - induced endothelial inflammation;Barabutis;Cytokine,2019
5. TRAF1 meditates lipopolysaccharide-induced acute lung injury by up regulating JNK activation;Bin;Biochem. Biophys. Res. Commun.,2019
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The efficacy of herbal medicines on the length of stay and negative conversion time/rate outcomes in patients with COVID-19: a systematic review;Frontiers in Pharmacology;2024-05-30
2. Design, synthesis and mechanism study of coumarin-sulfonamide derivatives as carbonic anhydrase IX inhibitors with anticancer activity;Chemico-Biological Interactions;2024-04
3. Effect and Mechanism of Reduning Injection on Respiratory Syncytial Virus (RSV)-Induced Airway Inflammation in Mice;International Journal of Pharmacology;2024-03-15
4. Reduning alleviates sepsis-induced acute lung injury by reducing apoptosis of pulmonary microvascular endothelial cells;Frontiers in Immunology;2023-07-03
5. A mathematic equation derived from host-pathogen interactions elucidates the significance of integrating modern medicine with traditional Chinese medicine to treat infectious diseases;Journal of Integrative Medicine;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3